Industry-Sponsored Research Week

Dartmouth and Qrons extend research agreement for 3-D printed hydrogels used in brain injury

By David Schwartz
Published: November 19th, 2019

Dartmouth Colleget and Qrons Inc., an emerging biotech company developing stem cell-synthetic hydrogel biomaterials for treating traumatic brain injuries (TBIs), have extended their research agreement for an additional year.

Professor Chenfeng Ke in Dartmouth’s chemistry department, who also serves on the Qrons Scientific Advisory Board, will continue as the Principal Investigator for the sponsored research.

Since July 2018, Qrons has been working with Professor Ke to develop 3D printable, biocompatible materials as a component of its stem cell-based TBI treatment. In October, Qrons inked a license agreement with Dartmouth for exclusive world-wide rights to related intellectual property.

Professor Ke commented, “Our project plan for the next year includes exploring a deeper level of integration of our hydrogels with cells and the surrounding environment to expand their adaptability for biomedical applications.” 

Jonah Meer, Qrons’ co-founder and CEO, added, “The extension of the Sponsored Research Agreement is a testament to the working relationship of our teams and the important work we’re doing together to improve the treatment of TBIs.”

Source: GlobeNewswire

Posted under: University-Industry Engagement Week

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment